Mag 7 Action Improves, But Biotech Keeps Delivering the Real Wins
While reverse rotation drives Nasdaq bounce, poor breadth suggests it can’t be trusted.
Weekly Sentiment Survey: Bulls and Bears in Equal Measure
While our team overwhelmingly continues to feel that risk is high, they’re not in agreement regarding what to do about it.
Broken Stocks Lead a Bounce as Small Caps Lag
The most beaten-up names enjoyed a reprieve, but don’t be too trusting.
The Chip Story Just Got More Complicated
AI Is bouncing, but a significant shift in the market is building. Here’s what to watch.
30 Signals Across the Portfolio’s 10 Themes and Strategies
Let’s scan through the headlines for the stories of the week that speak to our Pro Portfolio holdings.
Weekly Roundup: What We’re Watching as Markets Get Jiggy
We locked in massive gains on two positions and added to two beaten-down holdings.
Adding to Our Microsoft Position on Weakness
We’ll take advantage of the improved risk-to-reward tradeoff, and longer-term prospects.
I’m Eyeing 4 Stocks Today, Including One Hit By a Short Report
Let’s check that Morpheus report and why I want to see another ‘side’ to the story; also, three price targets shift.
Putting Our Palantir Game Plan Into Action
We would be open to adding further if we see this development